The heat-labile toxin (HLT) of Bordetella pertussis was purified by column chromatography on DEAE-cellulose, salt fractionation and preparative acrylamide gel electrophoresis.
A cell wall fraction obtained by sonic oscillation, yielded a Bordetella pertussis O antigen which possessed the ability to both adsorb O agglutinins and to produce the O agglutinins in animals. It was purified by a phenol water extraction and centrifugation method. Physico‐chemical and biological properties of the O antigen were similar to that of the so‐called endotoxic lipopolysaccharide. It contained 2.6% nitrogen, 1.2–1.5% phosphorus, 9.0–11.0% heptose, 0.3% 2‐keto‐3‐deoxyoctonate (KDO), 13.3–13.4% as total carbohydrate, 16–16.5% hexosamine and 25–32% lipid. Homogeneity of the purified O antigen was confirmed by ultracentrifugation, electronmicrograph and gel‐diffusion tests. It possessed significant pyrogenicity, adjuvant effect on antibody production, and toxicity to animals, but not protective antigenicity.
Relationship between K agglutinogenic factors of Bordetella pertussis were analyzed by agglutinin-adsorption tests. Factors 1 and 3 corresponded to L agglutinogen, while 2 and 4 corresponded to S agglutinogen. The experiment also indicates that B. pertussis phase I strains belong to a single serotype, while types 1-2-3, 1-2, 1-3 and 1 strains belong to the author's intermediate phase which probably arose from phase I parents. Strains isolated by us in 1952 to 1953 were type 1-2-3-4 which possessed both L and S, but a few strains isolated in 1962 and 1966 were type 1-3. The occurrence of such a defect in antigens was discussed. A single phase I vaccine seemed to give enough protection against various serotypes of pertussis organisms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.